Department of Molecular and Integrative Physiology, University of Michigan Medical School, 7744 Medical Science II, 1137 E. Catherine St., Ann Arbor, MI 48109-5622, USA.
FASEB J. 2011 Dec;25(12):4108-10. doi: 10.1096/fj.11-188052. Epub 2011 Oct 5.
The U.S. National Institutes of Health (NIH) are facing significant budgetary challenges as a result of the current economic climate. The recent sunset of investigator-initiated R01-type research grants after one revised submission, coupled with the present lack of an NIH retooling funding mechanism for such grant applicants, creates a concerning risk that talented and well-trained investigators may be forced to give up their research careers. Existing NIH retooling mechanisms include the R55 Shannon Award, which was established in 1991 and was essentially replaced in 2005 by the R56 award. There is an urgent need to either significantly expand the R55/R56 mechanisms and definition of NIH grant bridging/retooling support for unfunded meritorious proposals or introduce a new mechanism that provides specific support to investigators with competitive but unfunded R01 revised grants. An expanded retooling funding mechanism deserves implementation during continuing assessment of whether allowance of only one revision of research proposals has achieved its initial intended goals.
由于当前的经济形势,美国国立卫生研究院(NIH)正面临着重大的预算挑战。最近,经过一次修订提交后,调查员发起的 R01 型研究资助项目到期,而目前 NIH 没有为这类资助申请人提供重新调整资助机制的资金,这给有才华和训练有素的调查员带来了令人担忧的风险,他们可能被迫放弃自己的研究事业。现有的 NIH 重新调整机制包括 R55 Shannon 奖,该奖项于 1991 年设立,并于 2005 年基本上被 R56 奖取代。现在迫切需要要么大幅扩大 R55/R56 机制,并扩大 NIH 资助桥梁/重新调整机制的定义,以支持未获资助的有价值提案,要么引入一种新的机制,为具有竞争力但未获得资助的 R01 修订资助的调查员提供具体支持。在继续评估仅允许一次修订研究提案是否已达到其最初预期目标的过程中,应实施扩大的重新调整资金机制。